Biopharma
WuXi AppTec Faces Uncertainty Amid BIOSECURE Act, Yet Continues to Secure New Projects
BIOSECURE Act, WuXi AppTec, Biotechnology Industry, U.S. Legislation, Contract Development and Manufacturing Organizations (CDMOs), Biopharma Outsourcing, National Security Concerns
Novartis and Monte Rosa Collaborate on $2.2B Molecular Glue Degrader Alliance
Novartis, Monte Rosa, molecular glue degraders, biopharma collaboration, protein degradation, oncology, neurological diseases
Vanda Pharmaceuticals Rejects Cycle’s Second Takeover Bid Amid FDA Rejection of Tradipitant
Vanda Pharmaceuticals, Cycle Pharmaceuticals, takeover bid, FDA rejection, tradipitant, gastroparesis, biopharma, acquisition offer
Leo Pharma Announces Major Restructuring with Up to 250 Layoffs and Relocations
Leo Pharma, layoffs, relocations, restructuring, biopharma, job cuts
Pharmaceutical Industry Faces Widespread Layoffs Amid Economic Pressures
pharmaceutical layoffs, economic pressures, biopharma industry, job cuts, restructuring efforts
Biopharma Leaders Navigate AI ‘Hype Cycle’: Bayer, Daiichi Sankyo, and argenx Share Insights on AI Implementation in Marketing
AI in biopharma marketing, Bayer, Daiichi Sankyo, argenx, AI implementation, biopharma industry, AI hype cycle
Roche Secures FDA Approval for Subcutaneous Ocrevus and Tecentriq, Lilly Gains Approval for Eczema Treatment
FDA approvals, Roche, Subcutaneous products, Ocrevus, Tecentriq, Lilly, Eczema treatment, Pharmaceutical industry, Biopharma news
Charles River Laboratories Reduces Workforce by 3% Amid Q2 Revenue Decline
Charles River Laboratories, workforce reduction, layoffs, Q2 revenue drop, biopharma industry, restructuring initiatives
BridgeBio Unveils GondolaBio with $300M Investment, Transfers Key Programs to Joint Venture
BridgeBio, GondolaBio, Joint Venture, $300M Investment, Genetic Therapies, Biopharma Startup
Evotec Announces Restructuring Plan Amid Research Spending Slowdown
Evotec, layoffs, restructuring, research spending slowdown, gene therapy, biopharma